TY - JOUR AU - Hamdy, F. C. AU - Donovan, J. L. AU - Lane, J. A. AU - Mason, M. AU - Metcalfe, C. AU - Holding, P. PY - 2016 DA - 2016// TI - 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate Cancer JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1606220 DO - 10.1056/NEJMoa1606220 ID - Hamdy2016 ER - TY - STD TI - Neal DE, Metcalfe C, Donovan JL, Lane JA, Davis M, Young GJ, et al. Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received Eur Urol. 2019. doi: https://doi.org/10.1016/j.eururo.2019.10.030. ID - ref2 ER - TY - JOUR AU - Donovan, J. L. AU - Hamdy, F. C. AU - Lane, J. A. AU - Mason, M. AU - Metcalfe, C. AU - Walsh, E. PY - 2016 DA - 2016// TI - Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate Cancer JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1606221 DO - 10.1056/NEJMoa1606221 ID - Donovan2016 ER - TY - JOUR AU - Cuccia, F. AU - Mazzola, R. AU - Arcangeli, S. AU - Mortellaro, G. AU - Figlia, V. AU - Caminiti, G. PY - 2019 DA - 2019// TI - Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study JO - Tumori VL - 105 UR - https://doi.org/10.1177/0300891619867846 DO - 10.1177/0300891619867846 ID - Cuccia2019 ER - TY - JOUR AU - Fersino, S. AU - Tebano, U. AU - Mazzola, R. AU - Giaj-Levra, N. AU - Ricchetti, F. AU - Paola, G. PY - 2017 DA - 2017// TI - Moderate Hypofractionated Postprostatectomy volumetric modulated arc therapy with daily image guidance (VMAT-IGRT): a mono-institutional report on feasibility and acute toxicity JO - Clin Genitourin Cancer VL - 15 UR - https://doi.org/10.1016/j.clgc.2017.01.025 DO - 10.1016/j.clgc.2017.01.025 ID - Fersino2017 ER - TY - JOUR AU - Ruggieri, R. AU - Naccarato, S. AU - Stavrev, P. AU - Stavreva, N. AU - Fersino, S. AU - Giaj Levra, N. PY - 2015 DA - 2015// TI - Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer JO - Br J Radiol VL - 88 UR - https://doi.org/10.1259/bjr.20140736 DO - 10.1259/bjr.20140736 ID - Ruggieri2015 ER - TY - JOUR AU - Dearnaley, D. AU - Syndikus, I. AU - Mossop, H. AU - Khoo, V. AU - Birtle, A. AU - Bloomfield, D. PY - 2016 DA - 2016// TI - Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30102-4 DO - 10.1016/S1470-2045(16)30102-4 ID - Dearnaley2016 ER - TY - JOUR AU - Vries, K. C. AU - Wortel, R. C. AU - Oomen-de Hoop, E. AU - Heemsbergen, W. D. AU - Pos, F. J. AU - Incrocci, L. PY - 2020 DA - 2020// TI - Hyprofractionated versus conventionally fractionated radiation therapy for patients with intermediate- or high-risk, localized, prostate Cancer: 7-year outcomes from the randomized, multicenter, open-label, phase 3 HYPRO trial JO - Int J Radiat Oncol Biol Phys VL - 106 UR - https://doi.org/10.1016/j.ijrobp.2019.09.007 DO - 10.1016/j.ijrobp.2019.09.007 ID - Vries2020 ER - TY - BOOK PY - 2014 DA - 2014// TI - Clinical practice guidelines in oncology ID - ref9 ER - TY - JOUR AU - Brand, D. H. AU - Tree, A. C. AU - Ostler, P. AU - Voet, H. AU - Loblaw, A. AU - Chu, W. PY - 2019 DA - 2019// TI - Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial JO - Lancet Oncol VL - 20 UR - https://doi.org/10.1016/S1470-2045(19)30569-8 DO - 10.1016/S1470-2045(19)30569-8 ID - Brand2019 ER - TY - JOUR AU - Nicosia, L. AU - Mazzola, R. AU - Rigo, M. AU - Figlia, V. AU - Giaj-Levra, N. AU - Napoli, G. PY - 2019 DA - 2019// TI - Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients JO - J Cancer Res Clin Oncol VL - 145 UR - https://doi.org/10.1007/s00432-019-02983-3 DO - 10.1007/s00432-019-02983-3 ID - Nicosia2019 ER - TY - JOUR AU - Alongi, F. AU - Mazzola, R. AU - Fiorentino, A. AU - Corradini, S. AU - Aiello, D. AU - Figlia, V. PY - 2019 DA - 2019// TI - Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer JO - Strahlenther Onkol VL - 195 UR - https://doi.org/10.1007/s00066-018-1338-7 DO - 10.1007/s00066-018-1338-7 ID - Alongi2019 ER - TY - JOUR AU - Winkel, D. AU - Bol, G. H. AU - Kroon, P. S. AU - Asselen, B. AU - Hackett, S. S. AU - Werensteijn-Honingh, A. M. PY - 2019 DA - 2019// TI - Adaptive radiotherapy: The Elekta Unity MR-linac concept JO - Clin Transl Radiat Oncol VL - 18 UR - https://doi.org/10.1016/j.ctro.2019.04.001 DO - 10.1016/j.ctro.2019.04.001 ID - Winkel2019 ER - TY - BOOK AU - Fayers, P. M. AU - Aaronson, N. K. AU - Bjordal, K. PY - 2001 DA - 2001// TI - EORTC QLQ-C30 Scoring Manual PB - EORTC CY - Brussels ID - Fayers2001 ER - TY - JOUR AU - Andel, G. AU - Bottomley, A. AU - Fosså, S. D. PY - 2008 DA - 2008// TI - An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer JO - Eur J Cancer VL - 44 UR - https://doi.org/10.1016/j.ejca.2008.07.030 DO - 10.1016/j.ejca.2008.07.030 ID - Andel2008 ER - TY - JOUR AU - Szymanski, K. M. AU - Wei, J. T. AU - Dunn, R. L. AU - Sanda, M. G. PY - 2010 DA - 2010// TI - Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors JO - Urology. VL - 76 UR - https://doi.org/10.1016/j.urology.2010.01.027 DO - 10.1016/j.urology.2010.01.027 ID - Szymanski2010 ER - TY - JOUR AU - Bari, B. AU - Arcangeli, S. AU - Ciardo, D. AU - Mazzola, R. AU - Alongi, F. AU - Russi, E. G. PY - 2016 DA - 2016// TI - Extreme hypofractionation for early prostate cancer: biology meets technology JO - Cancer Treat Rev VL - 50 UR - https://doi.org/10.1016/j.ctrv.2016.08.005 DO - 10.1016/j.ctrv.2016.08.005 ID - Bari2016 ER - TY - JOUR AU - Corradini, S. AU - Alongi, F. AU - Andratschke, N. AU - Belka, C. AU - Boldrini, L. AU - Cellini, F. PY - 2019 DA - 2019// TI - MR-guidance in clinical reality: current treatment challenges and future perspectives JO - Radiat Oncol VL - 14 UR - https://doi.org/10.1186/s13014-019-1308-y DO - 10.1186/s13014-019-1308-y ID - Corradini2019 ER - TY - JOUR AU - Dewey, M. AU - Schink, T. AU - Dewey, C. F. PY - 2007 DA - 2007// TI - Claustrophobia during magnetic resonance imaging: cohort study in over 55,000 patients JO - J Magn Reson Imaging VL - 26 UR - https://doi.org/10.1002/jmri.21147 DO - 10.1002/jmri.21147 ID - Dewey2007 ER - TY - JOUR AU - Ame, B. AU - Tetar, S. U. AU - Oei, S. S. AU - Senan, S. AU - Haasbeek, C. J. A. AU - Spoelstra, F. O. B. PY - 2019 DA - 2019// TI - A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate Cancer: early toxicity results JO - Int J Radiat Oncol Biol Phys VL - 105 UR - https://doi.org/10.1016/j.ijrobp.2019.08.007 DO - 10.1016/j.ijrobp.2019.08.007 ID - Ame2019 ER - TY - JOUR AU - Stam, M. A. AU - Aaronson, N. K. AU - Bosch, J. L. H. R. AU - Kieffer, J. M. AU - Zyp, J. R. N. AU - Tillier, C. N. PY - 2020 DA - 2020// TI - Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices JO - Eur Urol Oncol VL - 3 UR - https://doi.org/10.1016/j.euo.2018.12.004 DO - 10.1016/j.euo.2018.12.004 ID - Stam2020 ER - TY - JOUR AU - Dess, R. T. AU - Hartman, H. E. AU - Aghdam, N. AU - Jackson, W. C. AU - Soni, P. D. AU - Abugharib, A. E. PY - 2018 DA - 2018// TI - Erectile function after stereotactic body radiotherapy for localized prostate cancer JO - BJU Int VL - 121 UR - https://doi.org/10.1111/bju.13962 DO - 10.1111/bju.13962 ID - Dess2018 ER -